We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 ...

Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...

Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...